SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Toloza, S.
Right arrow Articles by Gladman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toloza, S.
Right arrow Articles by Gladman, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

research-article

Association of killer cell immunoglobulin–like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus

SMA Toloza

Division of Rheumatology, Centre for Prognosis studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada

FJ Pellett

Division of Rheumatology, Centre for Prognosis studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada

V Chandran

Division of Rheumatology, Centre for Prognosis studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada

D Ibanez

Division of Rheumatology, Centre for Prognosis studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada

MB Urowitz

Division of Rheumatology, Centre for Prognosis studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada

DD Gladman

Division of Rheumatology, Centre for Prognosis studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada dafna.gladman{at}utoronto.ca

To determine whether killer cell immunologlobulin–like receptor (KIR) genotypes are associated with vasculitis, vascular arterial events or anticardiolipin (aCL) antibodies in patients with lupus. A total of 304 patients followed prospectively at the University of Toronto Lupus Clinic were assessed for the occurrence of vasculitis and vascular arterial events. Molecular HLA-C and KIR (presence or absence of KIR2DL1, 2DL2, 2DL3, 2DS1 and 2DS2) genotyping were performed. Chi-square and logistic regression were used to analyse association between KIR genes and vascular arterial events and aCL antibodies. In patients with vascular arterial events, there was a significant increase in KIR2DS2 (60% vs 45%, P = 0.02) and in KIR2DL2 (62% vs 47%, P = 0.01) compared with patients without events. There was no increase in activating KIR genotypes in patients with vasculitis. In patients with aCL antibodies, significant increases were seen in KIR2DS2 (54% vs 41%, P = 0.03) and KIR2DL2 (58% vs 41%, P = 0.003), but KIR2DL3 was decreased (87% vs 95%, P = 0.03). Logistic regression confirmed independent association of KIR2DS2 with vascular arterial events. We found an increase in KIR2DS2 in lupus patients with vascular arterial events, but not in patients with vasculitis.

Key Words: genetic associations • KIR genes • systemic lupus erythematosus • vascular arterial events

Lupus, Vol. 17, No. 9, 793-798 (2008)
DOI: 10.1177/0961203308089443


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
LupusHome page
Y-F. Hou, Y-C. Zhang, Y-L. Jiao, L-C. Wang, J-F. Li, Z-L. Pan, Q-R. Yang, H-S. Sun, and Y-R. Zhao
Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus
Lupus, January 1, 2010; 19(1): 20 - 26.
[Abstract] [PDF]



Advertisement